Do analysts rate UFPT or BLCO?

Bausch + Lomb has a consensus target price of $18.75, indicating a potential upside of 9.46%. Given Bausch + Lomb's stronger consensus rating and higher possible upside, analysts plainly believe Bausch + Lomb is more favorable than UFP Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score UFP Technologies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Bausch + Lomb 1 Sell rating(s) 7 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.31

Does the media refer more to UFPT or BLCO?

In the previous week, UFP Technologies had 4 more articles in the media than Bausch + Lomb. MarketBeat recorded 16 mentions for UFP Technologies and 12 mentions for Bausch + Lomb. UFP Technologies' average media sentiment score of 1.21 beat Bausch + Lomb's score of 0.31 indicating that UFP Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment UFP Technologies 12 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Bausch + Lomb 4 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 2 Very Negative mention(s) Neutral

Do analysts recommend UFPT or MMSI?

Merit Medical Systems has a consensus price target of $100.00, suggesting a potential upside of 10.51%. Given Merit Medical Systems' stronger consensus rating and higher possible upside, analysts clearly believe Merit Medical Systems is more favorable than UFP Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score UFP Technologies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Merit Medical Systems 0 Sell rating(s) 3 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.83

Does the media prefer UFPT or MMSI?

In the previous week, Merit Medical Systems had 8 more articles in the media than UFP Technologies. MarketBeat recorded 24 mentions for Merit Medical Systems and 16 mentions for UFP Technologies. Merit Medical Systems' average media sentiment score of 1.26 beat UFP Technologies' score of 1.21 indicating that Merit Medical Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment UFP Technologies 12 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Merit Medical Systems 11 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer ICUI or UFPT?

ICU Medical presently has a consensus target price of $192.80, indicating a potential upside of 10.11%. Given ICU Medical's stronger consensus rating and higher probable upside, equities research analysts plainly believe ICU Medical is more favorable than UFP Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ICU Medical 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 2 Strong Buy rating(s) 2.89 UFP Technologies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media refer more to ICUI or UFPT?

In the previous week, UFP Technologies had 6 more articles in the media than ICU Medical. MarketBeat recorded 16 mentions for UFP Technologies and 10 mentions for ICU Medical. ICU Medical's average media sentiment score of 1.37 beat UFP Technologies' score of 1.21 indicating that ICU Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ICU Medical 7 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive UFP Technologies 12 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend NVST or UFPT?

Envista presently has a consensus target price of $29.31, suggesting a potential upside of 7.95%. Given Envista's stronger consensus rating and higher possible upside, research analysts clearly believe Envista is more favorable than UFP Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Envista 0 Sell rating(s) 9 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.50 UFP Technologies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media favor NVST or UFPT?

In the previous week, UFP Technologies had 4 more articles in the media than Envista. MarketBeat recorded 16 mentions for UFP Technologies and 12 mentions for Envista. UFP Technologies' average media sentiment score of 1.21 beat Envista's score of 1.04 indicating that UFP Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Envista 10 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive UFP Technologies 12 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate UFPT or NEOG?

Neogen has a consensus price target of $12.00, indicating a potential upside of 2.92%. Given Neogen's stronger consensus rating and higher possible upside, analysts plainly believe Neogen is more favorable than UFP Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score UFP Technologies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Neogen 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40

Is UFPT or NEOG more profitable?

UFP Technologies has a net margin of 11.45% compared to Neogen's net margin of -0.91%. UFP Technologies' return on equity of 18.42% beat Neogen's return on equity. Company Net Margins Return on Equity Return on Assets UFP Technologies 11.45% 18.42% 11.96% Neogen -0.91% 2.78% 1.74%

Does the media refer more to UFPT or NEOG?

In the previous week, Neogen had 9 more articles in the media than UFP Technologies. MarketBeat recorded 25 mentions for Neogen and 16 mentions for UFP Technologies. UFP Technologies' average media sentiment score of 1.21 beat Neogen's score of 1.13 indicating that UFP Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment UFP Technologies 12 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Neogen 11 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

UFP Technologies (UFPT) Competitors

$300.05 +0.10 (+0.03%)

As of 08/28/2026 04:00 PM Eastern

Compare

UFPT vs. BLCO, MMSI, ICUI, NVST, and NEOG

Should you buy UFP Technologies stock or one of its competitors? UFP Technologies's main competitors and comparable companies include Bausch + Lomb (BLCO), Merit Medical Systems (MMSI), ICU Medical (ICUI), Envista (NVST), and Neogen (NEOG). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does UFP Technologies compare to Bausch + Lomb?

UFP Technologies (NASDAQ:UFPT) and Bausch + Lomb (NYSE:BLCO) are both mid-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, valuation, media sentiment, analyst recommendations, institutional ownership and dividends.

UFP Technologies has a net margin of 11.45% compared to Bausch + Lomb's net margin of -3.21%. UFP Technologies' return on equity of 18.42% beat Bausch + Lomb's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
UFP Technologies	11.45%	18.42%	11.96%
Bausch + Lomb	-3.21%	4.14%	1.93%

UFP Technologies has higher earnings, but lower revenue than Bausch + Lomb. Bausch + Lomb is trading at a lower price-to-earnings ratio than UFP Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
UFP Technologies	$602.80M	3.86	$68.31M	$9.28	32.33
Bausch + Lomb	$5.10B	1.20	-$360M	-$0.48	N/A

Bausch + Lomb has a consensus target price of $18.75, indicating a potential upside of 9.46%. Given Bausch + Lomb's stronger consensus rating and higher possible upside, analysts plainly believe Bausch + Lomb is more favorable than UFP Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
UFP Technologies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Bausch + Lomb	1 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.31

In the previous week, UFP Technologies had 4 more articles in the media than Bausch + Lomb. MarketBeat recorded 16 mentions for UFP Technologies and 12 mentions for Bausch + Lomb. UFP Technologies' average media sentiment score of 1.21 beat Bausch + Lomb's score of 0.31 indicating that UFP Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
UFP Technologies	12 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Bausch + Lomb	4 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	2 Very Negative mention(s)	Neutral

UFP Technologies has a beta of 1.08, meaning that its share price is 8% more volatile than the broader market. Comparatively, Bausch + Lomb has a beta of 0.56, meaning that its share price is 44% less volatile than the broader market.

87.3% of UFP Technologies shares are owned by institutional investors. Comparatively, 11.1% of Bausch + Lomb shares are owned by institutional investors. 4.6% of UFP Technologies shares are owned by insiders. Comparatively, 1.5% of Bausch + Lomb shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

UFP Technologies beats Bausch + Lomb on 12 of the 16 factors compared between the two stocks.

How does UFP Technologies compare to Merit Medical Systems?

UFP Technologies (NASDAQ:UFPT) and Merit Medical Systems (NASDAQ:MMSI) are both mid-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, media sentiment, institutional ownership, profitability and dividends.

Merit Medical Systems has higher revenue and earnings than UFP Technologies. UFP Technologies is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
UFP Technologies	$602.80M	3.86	$68.31M	$9.28	32.33
Merit Medical Systems	$1.52B	3.56	$128.49M	$2.42	37.39

Merit Medical Systems has a consensus price target of $100.00, suggesting a potential upside of 10.51%. Given Merit Medical Systems' stronger consensus rating and higher possible upside, analysts clearly believe Merit Medical Systems is more favorable than UFP Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
UFP Technologies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Merit Medical Systems	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.83

UFP Technologies has a net margin of 11.45% compared to Merit Medical Systems' net margin of 9.22%. UFP Technologies' return on equity of 18.42% beat Merit Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
UFP Technologies	11.45%	18.42%	11.96%
Merit Medical Systems	9.22%	13.75%	8.10%

UFP Technologies has a beta of 1.08, meaning that its stock price is 8% more volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.49, meaning that its stock price is 51% less volatile than the broader market.

87.3% of UFP Technologies shares are held by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are held by institutional investors. 4.6% of UFP Technologies shares are held by company insiders. Comparatively, 0.7% of Merit Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Merit Medical Systems had 8 more articles in the media than UFP Technologies. MarketBeat recorded 24 mentions for Merit Medical Systems and 16 mentions for UFP Technologies. Merit Medical Systems' average media sentiment score of 1.26 beat UFP Technologies' score of 1.21 indicating that Merit Medical Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
UFP Technologies	12 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Merit Medical Systems	11 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Merit Medical Systems beats UFP Technologies on 10 of the 17 factors compared between the two stocks.

How does UFP Technologies compare to ICU Medical?

ICU Medical (NASDAQ:ICUI) and UFP Technologies (NASDAQ:UFPT) are both mid-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, risk, profitability, media sentiment, valuation and dividends.

96.1% of ICU Medical shares are owned by institutional investors. Comparatively, 87.3% of UFP Technologies shares are owned by institutional investors. 2.1% of ICU Medical shares are owned by insiders. Comparatively, 4.6% of UFP Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

ICU Medical presently has a consensus target price of $192.80, indicating a potential upside of 10.11%. Given ICU Medical's stronger consensus rating and higher probable upside, equities research analysts plainly believe ICU Medical is more favorable than UFP Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ICU Medical	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	2 Strong Buy rating(s)	2.89
UFP Technologies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

UFP Technologies has a net margin of 11.45% compared to ICU Medical's net margin of 1.39%. UFP Technologies' return on equity of 18.42% beat ICU Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ICU Medical	1.39%	7.91%	4.17%
UFP Technologies	11.45%	18.42%	11.96%

ICU Medical has a beta of 0.74, indicating that its stock price is 26% less volatile than the broader market. Comparatively, UFP Technologies has a beta of 1.08, indicating that its stock price is 8% more volatile than the broader market.

In the previous week, UFP Technologies had 6 more articles in the media than ICU Medical. MarketBeat recorded 16 mentions for UFP Technologies and 10 mentions for ICU Medical. ICU Medical's average media sentiment score of 1.37 beat UFP Technologies' score of 1.21 indicating that ICU Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ICU Medical	7 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
UFP Technologies	12 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

UFP Technologies has lower revenue, but higher earnings than ICU Medical. UFP Technologies is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ICU Medical	$2.23B	1.96	$730K	$1.18	148.39
UFP Technologies	$602.80M	3.86	$68.31M	$9.28	32.33

Summary

UFP Technologies beats ICU Medical on 9 of the 17 factors compared between the two stocks.

How does UFP Technologies compare to Envista?

Envista (NYSE:NVST) and UFP Technologies (NASDAQ:UFPT) are both mid-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, dividends, profitability, earnings, analyst recommendations, risk and valuation.

87.3% of UFP Technologies shares are held by institutional investors. 1.0% of Envista shares are held by insiders. Comparatively, 4.6% of UFP Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Envista has a beta of 0.86, suggesting that its stock price is 14% less volatile than the broader market. Comparatively, UFP Technologies has a beta of 1.08, suggesting that its stock price is 8% more volatile than the broader market.

In the previous week, UFP Technologies had 4 more articles in the media than Envista. MarketBeat recorded 16 mentions for UFP Technologies and 12 mentions for Envista. UFP Technologies' average media sentiment score of 1.21 beat Envista's score of 1.04 indicating that UFP Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Envista	10 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
UFP Technologies	12 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Envista presently has a consensus target price of $29.31, suggesting a potential upside of 7.95%. Given Envista's stronger consensus rating and higher possible upside, research analysts clearly believe Envista is more favorable than UFP Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envista	0 Sell rating(s)	9 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.50
UFP Technologies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

UFP Technologies has lower revenue, but higher earnings than Envista. UFP Technologies is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envista	$2.72B	1.60	$47M	$0.58	46.81
UFP Technologies	$602.80M	3.86	$68.31M	$9.28	32.33

UFP Technologies has a net margin of 11.45% compared to Envista's net margin of 3.33%. UFP Technologies' return on equity of 18.42% beat Envista's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Envista	3.33%	7.88%	4.33%
UFP Technologies	11.45%	18.42%	11.96%

Summary

UFP Technologies beats Envista on 11 of the 17 factors compared between the two stocks.

How does UFP Technologies compare to Neogen?

UFP Technologies (NASDAQ:UFPT) and Neogen (NASDAQ:NEOG) are both mid-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, valuation, dividends, institutional ownership, earnings and media sentiment.

Neogen has a consensus price target of $12.00, indicating a potential upside of 2.92%. Given Neogen's stronger consensus rating and higher possible upside, analysts plainly believe Neogen is more favorable than UFP Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
UFP Technologies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Neogen	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

UFP Technologies has a beta of 1.08, suggesting that its share price is 8% more volatile than the broader market. Comparatively, Neogen has a beta of 1.77, suggesting that its share price is 77% more volatile than the broader market.

87.3% of UFP Technologies shares are owned by institutional investors. Comparatively, 96.7% of Neogen shares are owned by institutional investors. 4.6% of UFP Technologies shares are owned by company insiders. Comparatively, 0.6% of Neogen shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Neogen had 9 more articles in the media than UFP Technologies. MarketBeat recorded 25 mentions for Neogen and 16 mentions for UFP Technologies. UFP Technologies' average media sentiment score of 1.21 beat Neogen's score of 1.13 indicating that UFP Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
UFP Technologies	12 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Neogen	11 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

UFP Technologies has higher earnings, but lower revenue than Neogen. Neogen is trading at a lower price-to-earnings ratio than UFP Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
UFP Technologies	$602.80M	3.86	$68.31M	$9.28	32.33
Neogen	$870.40M	2.92	-$7.90M	-$0.03	N/A

UFP Technologies has a net margin of 11.45% compared to Neogen's net margin of -0.91%. UFP Technologies' return on equity of 18.42% beat Neogen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
UFP Technologies	11.45%	18.42%	11.96%
Neogen	-0.91%	2.78%	1.74%

Summary

UFP Technologies beats Neogen on 9 of the 16 factors compared between the two stocks.

Get UFP Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UFPT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

UFPT vs. The Competition

Export

Metric	UFP Technologies	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$2.32B	$5.88B	$7.21B	$12.91B
Dividend Yield	N/A	1.75%	2.54%	11.28%
P/E Ratio	32.33	25.92	273.16	25.42
Price / Sales	3.86	68.63	626.01	91.27
Price / Cash	24.29	33.03	76.74	53.00
Price / Book	5.03	6.18	12.98	6.14
Net Income	$68.31M	$149.01M	$3.48B	$348.86M
7 Day Performance	-2.94%	-0.24%	0.13%	-0.80%
1 Month Performance	17.63%	7.85%	8.37%	5.56%
1 Year Performance	42.77%	6.22%	24.55%	15.57%

UFP Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
UFPT UFP Technologies	2.065 of 5 stars	$300.05 +0.0%	N/A	+42.0%	$2.32B	$602.80M	32.33	5,349	News Coverage Positive News Insider Trade
BLCO Bausch + Lomb	3.1529 of 5 stars	$17.34 +0.6%	$18.75 +8.2%	+17.5%	$6.16B	$5.10B	N/A	13,000	Analyst Forecast
MMSI Merit Medical Systems	3.874 of 5 stars	$90.28 -0.6%	$100.00 +10.8%	+0.5%	$5.42B	$1.52B	37.31	7,500	Positive News Analyst Upgrade Analyst Revision
ICUI ICU Medical	3.4846 of 5 stars	$182.55 -0.2%	$192.80 +5.6%	+37.8%	$4.57B	$2.16B	154.70	13,000	Positive News
NVST Envista	2.9883 of 5 stars	$27.34 +0.5%	$29.31 +7.2%	+27.8%	$4.37B	$2.72B	47.15	12,000	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:UFPT) was last updated on 8/29/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

UFP Technologies (UFPT) Competitors

UFPT vs. BLCO, MMSI, ICUI, NVST, and NEOG

How does UFP Technologies compare to Bausch + Lomb?

Summary

How does UFP Technologies compare to Merit Medical Systems?

Summary

How does UFP Technologies compare to ICU Medical?

Summary

How does UFP Technologies compare to Envista?

Summary

How does UFP Technologies compare to Neogen?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

UFPT vs. The Competition

UFP Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

UFP Technologies (UFPT) Competitors

UFPT vs. BLCO, MMSI, ICUI, NVST, and NEOG

How does UFP Technologies compare to Bausch + Lomb?

Is UFPT or BLCO more profitable?

Which has preferable valuation and earnings, UFPT or BLCO?

Do analysts rate UFPT or BLCO?

Does the media refer more to UFPT or BLCO?

Which has more volatility and risk, UFPT or BLCO?

Do insiders & institutionals have more ownership in UFPT or BLCO?

Summary

How does UFP Technologies compare to Merit Medical Systems?

Which has higher earnings & valuation, UFPT or MMSI?

Do analysts recommend UFPT or MMSI?

Is UFPT or MMSI more profitable?

Which has more risk and volatility, UFPT or MMSI?

Do insiders & institutionals believe in UFPT or MMSI?

Does the media prefer UFPT or MMSI?

Summary

How does UFP Technologies compare to ICU Medical?

Do institutionals & insiders believe in ICUI or UFPT?

Do analysts prefer ICUI or UFPT?

Is ICUI or UFPT more profitable?

Which has more risk & volatility, ICUI or UFPT?

Does the media refer more to ICUI or UFPT?

Which has better earnings & valuation, ICUI or UFPT?

Summary

How does UFP Technologies compare to Envista?

Do insiders and institutionals believe in NVST or UFPT?

Which has more volatility & risk, NVST or UFPT?

Does the media favor NVST or UFPT?

Do analysts recommend NVST or UFPT?

Which has preferable earnings & valuation, NVST or UFPT?

Is NVST or UFPT more profitable?

Summary

How does UFP Technologies compare to Neogen?

Do analysts rate UFPT or NEOG?

Which has more volatility & risk, UFPT or NEOG?

Do institutionals and insiders have more ownership in UFPT or NEOG?

Does the media refer more to UFPT or NEOG?

Which has higher earnings and valuation, UFPT or NEOG?

Is UFPT or NEOG more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

UFPT vs. The Competition

UFP Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools